The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
The planning committee chairman did a great job today. He dealt with the grey areas by referring them to the experts to be dealt with:
Was it fracking? He got the planning officer to explain it wasn't.
Would the roads be more unsafe? He got the Highways officer to explain they wouldn't.
What about government policy on energy security? He got the planning officer to explain current guidance - that energy security MUST be a consideration.
Well done sir.
Now, there were a few posters on here adamant this wouldn't be passed. Were they ignorant, or just trying to deceive? Hopefully they were ignorant.
Feeks, the only difference between Wressle and West Newton planning committee decisions, is that at Wressle refusal was led by the unions, and West newton refusal was led by nimbys. If you look at the reasons you'll see they're pretty much the same. Each application once renewed is reset - bearing in mind the number of refusals and reapplications for both sites is irrelevant. Therefore costs associated would be similar.
I'm not sure you really understand the procedure Feeks, and the more you are arguing, the bigger the hole you are digging.
This Thursday either the planning committee will pass the West Newton application, or they will lose at appeal and have to pay many 100's of k in costs. They know that. They are not stupid people.
Thanks Demon. I should be able to find it.
Where can I find this presentation please?
Hi Swap. Surprised you'd remember me mate. You should be well up! I chose to take a step back from the bb for a while. Getting too many confusing messages. ATB.
Thanks.
Surely they're 20 minutes each? So 7pm?
Amryt - no way. It will have to be a special purpose acquisition company (SPAC) also known as a blank cheque company. The company that either buys Imutex or Imutex merges into will have to have huge funds to be able to bring on the vaccines. imo
The SPAC will have to be both NASDAQ and London listed. If this spin off can capture the imagination of investors (and let's face it, it should right now), it could be worth far more than any big pharma will be prepared to pay.
That wasn't an acrostic, was it Swap?
I'm fine thanks Swap. You sound okay - just a little frazzled.
Just to expand, CF keeps mentioning merging or selling to a SPAC as the way to get NASDAQ listed. The SPAC would also have to be London listed. I have no doubt he will have spoken to many SPAC investors to test the water, and if I remember rightly he is doing a presentation specifically for them tomorrow.
We would obviously get one share in the NASDAQ company for each ORPH share we hold, but clearly the SPAC funders would also get shares, depending upon whatever deal CF can negotiate.
However, if we sell to the SPAC rather than merge with it, it will be the same as selling to a big pharma company, and we won't have shares in it.
Swap, NASDAQ listing doesn't necessarily mean we don't sell. We could sell to a NASDAQ and London listed SPAC, rather than merge into one. Either way we won't need funding - that will come from the SPAC.
Sally, I don't think it will leak out. The first we should know is an RNS in a couple of months or so that a big pharma company has bought it, or not much later we'll here that the Imutex bundle is being merged or bought by a NASDAQ and London listed SPAC.
I think you're right mmar.